Viewing Study NCT04189757


Ignite Creation Date: 2025-12-24 @ 6:51 PM
Ignite Modification Date: 2025-12-25 @ 4:23 PM
Study NCT ID: NCT04189757
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-21
First Post: 2019-12-03
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Acalabrutinib for the Treatment of Ibrutinib-Intolerant Mantle Cell Lymphoma
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module